{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:01:52Z","timestamp":1781456512685,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.humimm.2025.111632","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T22:39:52Z","timestamp":1765319992000},"page":"111632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunoglobulin \u03b3 allotypes influence the level of autoantibody responses to amyloid-\u03b2 in patients with Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9992-4737","authenticated-orcid":false,"given":"Janardan P.","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9251-939X","authenticated-orcid":false,"given":"Christine","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3933-4986","authenticated-orcid":false,"given":"Paul J.","family":"Nietert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8810-620X","authenticated-orcid":false,"given":"James J.","family":"Lah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2025.111632_b0005","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.4049\/jimmunol.2000351","article-title":"An Ig \u03b3 marker genotype is a strong risk factor for Alzheimer\u2019s disease, independent of apolipoprotein E \u03b54 genotype","volume":"205","author":"Pandey","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2025.111632_b0010","doi-asserted-by":"crossref","unstructured":"J.P. Pandey, 2025. Immunoglobulin GM (\u03b3 marker) allotypes and their role in immune response and disease susceptibility. J Immunol. Aug 7, vkaf190. https:\/\/doi.org\/10.1093\/jimmun\/vkaf190.","DOI":"10.1093\/jimmun\/vkaf190"},{"key":"10.1016\/j.humimm.2025.111632_b0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.21475","article-title":"Autoantibodies against \u03b2-amyloid are common in Alzheimer's disease and help control plaque burden","volume":"65","author":"Kellner","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.humimm.2025.111632_b0020","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","article-title":"Alzheimer's disease: from immunotherapy to immunoprevention","volume":"186","author":"Jucker","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2025.111632_b0025","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/S0140-6736(24)01883-X","article-title":"Passive anti-amyloid \u03b2 immunotherapy in Alzheimer's disease-opportunities and challenges","volume":"404","author":"Heneka","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2025.111632_b0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2162-3619-2-6","article-title":"The forgotten tale of immunoglobulin allotypes in cancer risk and treatment","volume":"2","author":"Pandey","year":"2013","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.humimm.2025.111632_b0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","article-title":"Version 3 of the national Alzheimer's coordinating center's uniform data set","volume":"32","author":"Besser","year":"2018","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.humimm.2025.111632_b0040","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcf.2021.06.011","article-title":"Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients","volume":"20","author":"Pandey","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.humimm.2025.111632_b0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00241259","article-title":"DNA sequences specific for Caucasian G3m(b) and (g) allotypes: allotyping at the genomic level","volume":"39","author":"Balb\u00edn","year":"1994","journal-title":"Immunogenetics"},{"key":"10.1016\/j.humimm.2025.111632_b0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0888-7543(92)90208-A","article-title":"Polymerase chain reaction-based genotyping for allotypic markers of immunoglobulin kappa shows allelic association of Km with kappa variable segment","volume":"13","author":"Moxley","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.humimm.2025.111632_b0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing\u2013when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.humimm.2025.111632_b0060","doi-asserted-by":"crossref","first-page":"13917","DOI":"10.1074\/jbc.M700661200","article-title":"The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen","volume":"282","author":"Torres","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2025.111632_b0065","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/301720a0","article-title":"An idiotypic determinant formed by both immunoglobulin constant and variable regions","volume":"301","author":"Morahan","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2025.111632_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.2184","article-title":"A new synthesis for antibody-mediated immunity","volume":"13","author":"Casadevall","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2025.111632_b0075","doi-asserted-by":"crossref","unstructured":"A. Izadi, A. Hailu, Godzwon M, Wrighton S, Olofsson B, Schmidt, et al., 2023. Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization. Proc Natl Acad Sci USA. 120, e2217590120.","DOI":"10.1073\/pnas.2217590120"},{"key":"10.1016\/j.humimm.2025.111632_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102595","article-title":"Disease-modifying therapies for Alzheimer's disease: clinical trial progress and opportunity","volume":"103","author":"Zhang","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.humimm.2025.111632_b0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbi.2025.06.001","article-title":"A Novel A\u03b2 B-cell epitope vaccine, A\u03b21-10 with carrier protein OVA and KLH reduce A\u03b2-induced neuroinflammation mediated neuropathology in mouse model of Alzheimer's disease","volume":"129","author":"Park","year":"2025","journal-title":"Brain Behav. Immun."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925004033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925004033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:47:17Z","timestamp":1781455637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925004033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0198885925004033"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111632","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoglobulin \u03b3 allotypes influence the level of autoantibody responses to amyloid-\u03b2 in patients with Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"111632"}}